Claudia Janda, Ph.D.

Principal Investigator,
Princess Maxima Center for Pediatric Oncology

Claudia Janda is currently a Senior Scientist at Surrozen. She brings more than 7 years of experience as a protein biochemist analyzing structure-function relationships of ligand-receptor systems relevant to human health and disease. Dr. Janda’s work has also applied protein engineering approaches to modulate signaling, with a primary focus on Wnt signaling. Most recently, she was a Research Scientist and Postdoctoral Associate in the laboratory of Prof. K. Christopher Garcia at Stanford University. During her tenure at Stanford, Dr. Janda developed the surrogate Wnt ligand technology behind Surrozen’s platform and published seminal work on the first crystal structure of a Wnt protein bound to the extracellular domain of a Frizzled receptor. Dr. Janda obtained her Ph.D. in Molecular Biology from the Laboratory of Molecular Biology (MRC-LMB), and the University of Cambridge, U.K, and holds a Master of Science from the Swiss Federal Institute of Technology in Zurich.